Maxime Brunet Emmanuel Khalifa Antoine Italiano
10.3389/fonc.2019.01204
Front Oncol
2019 Nov 12;9:1204.
braf ameloblastoma precision oncology rare tumor targeted therapeutic drugs
CC BY
https://pubmed.ncbi.nlm.nih.gov/31781502/
Case Reports
PMC6861385
31781502
Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma
2019